Synergistic Herbal Pain Composition for Opioid Use Reduction

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

There is a need for alternative pain management strategies that reduce reliance on opioids while providing effective analgesia, as opioids are associated with significant adverse effects such as addiction, tolerance, and overdose, and existing pharmaceutical approaches have had limited success.

Innovation Solution

Pharmaceutical compositions comprising synergistic combinations of herbal compounds like Mitragyna speciosa, Piper methysticum, Curcuma longa, Scutellaria baicalensis, Piper nigrum, Cannabis sativa, Sophora japonica, and 4-amino-3-phenylbutanoic acid (phenibut) are formulated to target multiple biological pathways, reducing pain and opioid use.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If opioids are used for pain management, then effective analgesia is achieved, but addiction and tolerance develop

Engineering Contradiction:

Improvepain relief efficacyVSAvoidaddiction and tolerance

Core Design Contradiction:

ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent combines multiple herbal compounds (kratom, kava, turmeric, Chinese skullcap, black pepper, green tea, valerian, and phenibut) into a composite formulation. Each component targets different biological pathways: kratom provides opioid-like effects through mitragynine, kava offers anxiolytic properties, turmeric reduces inflammation via curcumin, and phenibut modulates GABA receptors. This multi-component approach achieves effective pain relief while avoiding the addictive properties of pure opioids by distributing the therapeutic effect across multiple mechanisms.

Inventive Principle:

Principle #40Composite materials

Solution Approach 2:

The herbal composition performs multiple functions simultaneously: analgesia through kratom's mu-opioid receptor interaction, anti-inflammatory effects via curcumin, anxiolytic action through kava and phenibut, and sleep promotion via valerian. This multi-functionality allows the formulation to address pain while reducing opioid dependence through combined mechanisms rather than relying on a single opioid compound.

Inventive Principle:

Principle #6Universality (Multi-functionality)

2Measurement precision

If highly selective molecules targeting single biological targets are used, then molecular precision is achieved, but effective opioid alternatives are not developed

Engineering Contradiction:

Improvetarget binding specificityVSAvoideffective pain management

Core Design Contradiction:

Measurement precisionVSReliability

Solution Approach 1:

Instead of using a single highly selective molecule targeting one biological pathway, the patent inverts the approach by employing multiple herbal compounds that each interact with different targets. The formulation includes kratom for opioid receptor activation, curcumin for COX-2 inhibition, kava for GABA modulation, and phenibut for glutamate receptor interaction. This inverted strategy achieves effective pain management through polypharmacy rather than monotherapy with high specificity.

Inventive Principle:

Principle #13The other way round (Inversion)

Solution Approach 2:

The patent creates a composite herbal formulation where multiple compounds work synergistically across different biological pathways. The combination includes alkaloids from kratom, lactones from kava, curcuminoids from turmeric, and GABA analogs from phenibut, each contributing to the overall analgesic effect through distinct mechanisms, thereby achieving reliable pain management without relying on single-target specificity.

Inventive Principle:

Principle #40Composite materials

3Adaptability or versatility

If traditional medicine approaches using herbal medicines are used, then multi-target effects are achieved, but safety and efficacy are not well established

Engineering Contradiction:

Improvemulti-target biological pathwaysVSAvoidsafety and efficacy establishment

Core Design Contradiction:

Adaptability or versatilityVSReliability

Solution Approach 1:

The patent performs preliminary actions by carefully selecting and standardizing specific herbal components with known active constituents. Each herb is chosen based on established phytochemical profiles: kratom for mitragynine content, kava for kavalactones, turmeric for curcumin, and phenibut for its pure GABA analog structure. This preliminary characterization of active ingredients provides a foundation for establishing safety and efficacy through controlled dosing of identified compounds rather than unstandardized herbal extracts.

Inventive Principle:

Principle #10Preliminary action

Data Source

PatentUS20260000726A1Synergistic Herbal Compositions for Pain Management and Opioid Use Reduction

Publication Date: 2026.01.01 PFOHL JEFFREY L

AI summary

Pharmaceutical compositions comprising synergistic combinations of herbal compounds from Mitragyna speciosa, Piper methysticum, Curcuma longa, Scutellaria baicalensis, Piper nigrum, Cannabis sativa, Camellia sinensis, Sophora japonica, and optionally Valeriana officinalis and 4-amino-3-phenylbutanoic acid are provided for treating pain and reducing opioid use. The compositions comprise defined ratios of the extracts optimized for enhanced analgesic efficacy and opioid-sparing effects. Methods of administering the compositions to subjects in need thereof result in significant reductions in pain and opioid use compared to the individual components. The unique multi-component formulations take advantage of synergistic interactions between extracts with analgesic, anxiolytic, and opioid use disorder mitigating properties.